March 5, 2015.
AbbVie Inc. (North Chicago, IL) is to buy Pharmacyclics (Sunnyvale, CA) for "about $21 billion", Reuters reports today.
The deal will give AbbVie access to what is expected to be one of the world's top-selling cancer drugs: Pharmacyclics' blood cancer treatment Imbruvica is predicted to hit $1 billion in US sales this year, with worldwide sales to reach $5.8 billion by 2020, according to Thomson Reuters Cortellis.
Plan Ahead: Mastering Your AI Budget for 2025 Success
October 9th 2024Generative AI is just one part of the artificial intelligence and machine learning that is being used by life science organizations, emerging as a major area of interest and an area in which costs and ROI are still largely unknown.